Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CYP2D6 Polymorphism Defining UM, IM, NM and PM Status in Unselected Medically Treated Patients of General Practice in Austria

NCT03859622 is registered in ClinicalTrials.gov with Karl Landsteiner Institute for Systematics in General Medicine as lead sponsor.

NCT NCT03859622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03859622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CYP2D6 Polymorphism Defining UM, IM, NM and PM Status in Unselected Medically Treated Patients of General Practice in Austria
Lead sponsor
Karl Landsteiner Institute for Systematics in General Medicine
Phase
Observational
Overall status
Completed
Start date
October 9, 2017
Completion date
October 9, 2018
Enrollment
289 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder due cytochrome p450 cyp2d6 variant